A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf.
Patient noncompliance as the cause of skin toxicity in capecitabine therapy
2022
MD-Onco
Preserved Fulltext
When using capecitabine, manifestations of toxicity in the form of palmar-plantar dysesthesia, redness, excessive sensitivity and peeling of the skin of the palms and feet are well known. However, in the scientific literature available to us, we did not find a single case of skin toxicity with capecitabine, in contrast to targeted therapy, for which skin manifestations are very characteristic. The dermal toxicity described in this paper developed as a result of patient noncompliance. These side
doi:10.17650/2782-3202-2022-2-3-55-58
fatcat:jh57rpod3nehdjmmnv73k57lre